What's breaking now, across thousands of outlets.
MILAN — Forget Wegovy and Zepbound. Never mind CagriSema, and even retatrutide. The latest big name in obesity is eloraTZP. Data revealed Wednesday show that Lilly's amylin-incretin combination delivered weight loss of up to 23.3% at ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The Senate Health, Education, Labor and Pensions Committee advanced President Trump's pick for the next surgeon general, sending Nicole Saphier's nomination to the full Senate.
A decade after 10 people died during the world’s largest and most catastrophic thunderstorm asthma event, there are concerns about the season to come.
A decade after 10 people died during the world’s largest and most catastrophic thunderstorm asthma event, there are concerns about the season to come.
President Trump's nominee for U.S. surgeon general advanced through a key Senate committee on Wednesday, setting up a glide path to a floor vote and confirmation.
A former congressman will take over for prominent lobbyist Steve Ubl. Elsewhere, recent buyout deals paid dividends for Mirum and AbbVie.
Genetic markers in the blood that can signal lung cancer risk up to 10 years before a person is diagnosed have been discovered by University of Hawaiʻi researchers.
